InterX

InterX is a biotechnology startup that revolutionizes biomolecular computing, focusing on developing new therapies to combat cancer. This fully leverages our in-depth knowledge of transcriptional regulation and the novel computational and structural methods we are developing. Our goal is to achieve robust and accurate predictions of the molecular and holistic properties of biological systems. Led by a team of Nobel Prize-winning scientists, InterX is committed to tools for drug ligand design, materials science, and biochemistry.